9bl9: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==KIR3DL1*114 in complex with HLA-A*24:02 presenting the NEF peptide== | |||
<StructureSection load='9bl9' size='340' side='right'caption='[[9bl9]], [[Resolution|resolution]] 2.60Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[9bl9]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Human_immunodeficiency_virus Human immunodeficiency virus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=9BL9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=9BL9 FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.6Å</td></tr> | |||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=9bl9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=9bl9 OCA], [https://pdbe.org/9bl9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=9bl9 RCSB], [https://www.ebi.ac.uk/pdbsum/9bl9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=9bl9 ProSAT]</span></td></tr> | |||
</table> | |||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
Genetic variation in host immunity impacts the disproportionate burden of infectious diseases that can be experienced by First Nations peoples. Polymorphic human leukocyte antigen (HLA) class I and killer cell immunoglobulin-like receptors (KIRs) are key regulators of natural killer (NK) cells, which mediate early infection control. How this variation impacts their responses across populations is unclear. We show that HLA-A( *)24:02 became the dominant ligand for inhibitory KIR3DL1 in First Nations peoples across Oceania, through positive natural selection. We identify KIR3DL1( *)114, widespread across and unique to Oceania, as an allele lineage derived from archaic humans. KIR3DL1( *)114(+)NK cells from First Nations Australian donors are inhibited through binding HLA-A( *)24:02. The KIR3DL1( *)114 lineage is defined by phenylalanine at residue 166. Structural and binding studies show phenylalanine 166 forms multiple unique contacts with HLA-peptide complexes, increasing both affinity and specificity. Accordingly, assessing immunogenetic variation and the functional implications for immunity are fundamental toward understanding population-based disease associations. | |||
An archaic HLA class I receptor allele diversifies natural killer cell-driven immunity in First Nations peoples of Oceania.,Loh L, Saunders PM, Faoro C, Font-Porterias N, Nemat-Gorgani N, Harrison GF, Sadeeq S, Hensen L, Wong SC, Widjaja J, Clemens EB, Zhu S, Kichula KM, Tao S, Zhu F, Montero-Martin G, Fernandez-Vina M, Guethlein LA, Vivian JP, Davies J, Mentzer AJ, Oppenheimer SJ, Pomat W, Ioannidis AG, Barberena-Jonas C, Moreno-Estrada A, Miller A, Parham P, Rossjohn J, Tong SYC, Kedzierska K, Brooks AG, Norman PJ Cell. 2024 Nov 27;187(24):7008-7024.e19. doi: 10.1016/j.cell.2024.10.005. Epub , 2024 Oct 29. PMID:39476840<ref>PMID:39476840</ref> | |||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |||
[[Category: | </div> | ||
[[Category: Faoro | <div class="pdbe-citations 9bl9" style="background-color:#fffaf0;"></div> | ||
[[Category: Rossjohn | == References == | ||
<references/> | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Homo sapiens]] | |||
[[Category: Human immunodeficiency virus]] | |||
[[Category: Large Structures]] | |||
[[Category: Faoro C]] | |||
[[Category: Rossjohn J]] | |||